期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

髓样细胞触发受体-1在炎症性肠病中的研究进展 被引量：4

Role of triggering receptor expressed on myeloid cells-1 in inflammatory bowel disease
原文传递
导出
摘要 炎症性肠病(IBD)是一组病因不明且反复发作的肠道慢性炎症性疾病,既往已有的证据表明宿主不恰当的免疫反应与IBD的发生密切相关。越来越多的研究表明髓样细胞触发受体(TREM)-1可以调节多种信号通路,参与IBD的发生和发展,本文综述TREM-1在IBD中的研究进展,进一步阐明IBD的发生机制。 Inflammatory bowel disease(IBD)is a group of recurrent chronic intestinal inflammatory diseases.The precise etiology of IBD remains unclear,but the inappropriate immune response is considered the leading cause of IBD.More and more studies indicated that triggering receptor expressed on myeloid cells(TREM)-1 have regulated multiple signaling pathways.This review will focus specifically on recent insights into the role of TREM-1 proteins in IBD development,and discuss opportunities for novel treatment approaches.
作者 耿丽 张目涵 王许平 王丹丹 杨贝贝 高闯 杜晓博 冯百岁 Geng Li;Zhang Muhan;Wang Xuping;Wang Dandan;Yang Beibei;Gao Chuang;Du Xiaobo;Feng Baisui(Department of Gastroenterology,The Second Affiliated Hospital,Zhengzhou University,Zhengzhou 450014,China)
机构地区 郑州大学第二附属医院消化内科
出处 《中华炎性肠病杂志（中英文）》 2020年第2期154-157,共4页 Chinese Journal of Inflammatory Bowel Diseases
基金 国家自然科学基金资助项目(81070288、81270452) 河南省自然科学基金项目(162300410268) 河南省医学科技攻关计划项目(201502015)。
关键词 炎症性肠病 髓样细胞触发受体1 TOLL样受体 可溶性髓样细胞触发受体1 Inflammatory bowel disease Triggering receptor expressed on myeloid cells-1 Toll-like receptor Soluble triggering receptor expressed on myeloid cells-1
分类号 R57 [医药卫生—消化系统]
  • 相关文献

参考文献2

二级参考文献20

  • 1[1]Targan SR,Karp LC.Defects in mucosal immunity leading to ulcerative colitis.Immunol Rev 2005; 206:296-305
  • 2[2]Tlaskalova-Hogenova H,Tuckova L,Stepankova R,Hudcovic T,Palova-Jelinkova L,Kozakova H,Rossmann P,Sanchez D,Cinova J,Hrncir T,Kverka M,Frolova L,Uhlig H,Powrie F,Bland P.Involvement of innate immunity in the development of inflammatory and autoimmune diseases.Ann N Y Acad Sci 2005; 1051:787-798
  • 3[3]Sandborn WJ,Hanauer SB.Antitumor necrosis factor therapy for inflammatory bowel disease:a review of agents,pharmacology,clinical results,and safety.Inflamm Bowel Dis 1999; 5:119-133
  • 4[4]Gibot S,Cravoisy A,Levy B,Bene MC,Faure G,Bollaert PE.Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia.N Engl JMed 2004; 350:451-458
  • 5[5]Gibot S,Kolopp-Sarda MN,Bene MC,Bollaert PE,Lozniewski A,Mory F,Levy B,Faure GC.A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis.J Exp Med 2004; 200:1419-1426
  • 6[6]Schenk M,Bouchon A,Birrer S,Colonna M,Mueller C.Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine.J Immunol 2005; 174:517-524
  • 7[7]Koussoulas V,Vassiliou S,Demonakou M,Tassias G,Giamarellos-Bourboulis EJ,Mouktaroudi M,Giamarellou H,Barbatzas C.Soluble triggering receptor expressed on myeloid cells (sTREM-1):a new mediator involved in the pathogenesis of peptic ulcer disease.Eur J Gastroenterol Hepatol 2006; 18:375-379
  • 8[8]Louis E,Collard A,Oger AF,Degroote E,Aboul Nasr El Yafi FA,Belaiche J.Behaviour of Crohn's disease according to the Vienna classification:changing pattern over the course of the disease.Gut 2001; 49:777-782
  • 9[9]Farmer M,Petras RE,Hunt LE,Janosky JE,Galandiuk S.The importance of diagnostic accuracy in colonic inflammatory bowel disease.Am J Gastroenterol 2000; 95:3184-3188
  • 10[10]Sostegni R,Daperno M,Scaglione N,Lavagna A,Rocca R,Pera A.Review article:Crohn's disease:monitoring disease activity.Aliment Pharmacol Ther 2003; 17 Suppl 2:11-17

共引文献80

同被引文献24

引证文献4

二级引证文献8

中华炎性肠病杂志（中英文）
2020年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部